サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1624233

単核球症診断市場規模・予測、世界・地域シェア、動向、成長機会分析レポート：タイプ別、エンドユーザー別、地域別

Mononucleosis Diagnostic Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, End User, and Geography

出版日
ページ情報
英文 210 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
単核球症診断市場規模・予測、世界・地域シェア、動向、成長機会分析レポート：タイプ別、エンドユーザー別、地域別
出版日: 2024年11月27日
発行: The Insight Partners
ページ情報: 英文 210 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

弊社の最新調査レポート「単核球症診断市場の2031年までの予測-世界分析-タイプ別、エンドユーザー別、地域別」によると、市場は2023年の1億5,144万米ドルから成長し、2031年には2億2,215万米ドルに達すると予測され、2023年から2031年にかけてCAGR 4.9%を記録すると予測されています。思春期人口におけるリスクの高さ、単核症に関する健康意識と知識の高まりが、単核症診断市場規模の拡大に寄与しています。しかし、既存の診断テストの精度が低いことが、単核球症診断市場の成長を妨げています。さらに、単核球症診断における分子診断学の進歩は、今後数年間で新しい単核球症診断市場動向をもたらすと予想されます。

売上高では、北米が2023年の単核球症診断市場を独占しました。予測期間中も世界市場を独占すると推定されます。米国は世界最大の単核球症診断市場であり、予測期間中も市場を独占すると予測されます。米国における単核球症診断市場の成長は、技術の進歩、認知度の向上、効果的な疾病管理戦略への絶え間ないニーズに起因しています。米国国立衛生研究所によると、米国では毎年125,000件の伝染性単核症が発生しています。このような患者数の多さから、エプスタイン・バー・ウイルス（EBV）に起因する単核球症に対する認識も高まっており、迅速かつ正確な診断検査キット、消耗品、サービスの需要が高まっています。同国のヘルスケアプロバイダーが採用しているさまざまな検査法には、抗体検出に基づく血清学的検査やウイルスDNA同定に焦点を当てた分子検査があります。米国における単核球症診断市場の競合情勢は、アボット・ラボラトリーズ、ロシュ・ダイアグノスティックス、シーメンス・ヘルスイニアーズなどの企業が支配的です。これらの企業は、製品ラインナップを強化し、市場でのプレゼンスを拡大するため、技術革新や提携に投資しています。

単核球症診断市場分析

POC検査の開発が今後の市場機会をもたらす

POC検査は、患者の治療現場またはその近くで迅速な診断を可能にし、ヘルスケア提供者が即座に臨床判断を下し、患者の転帰を改善することを可能にします。従来の臨床検査では、結果が出るまでに数時間から数日を要することが多く、治療が遅れたり症状が悪化したりする可能性があります。対照的に、POC検査は数分以内に結果を出すことができ、タイムリーな介入を容易にします。早期の診断は合併症を減らし、患者の快適性を高めることができるため、迅速な結果は単核球症などの疾患にとって特に重要です。POC検査は、外来診療所、救急部、在宅ケアなど、さまざまなヘルスケア環境で実施できます。検査インフラが限られている地域や、ヘルスケア資源が不十分な地方では、アクセスのしやすさは特に有益です。POC検査という形で診断能力を患者に近づけることで、より多くの人がタイムリーな診断と適切なケアを受けられるようになり、医療サービスの範囲が広がります。さらに、この種の検査は、患者が迅速に結果を受け取り、次のステップについてヘルスケアプロバイダーと話し合うことができるため、より大きなエンゲージメントを促進します。

POC検査は、大規模な検査インフラを必要としないため、従来の検査室検査に比べて費用対効果が高く、ひいてはヘルスケア・システム全体のコストを下げることができます。単核球症検査の手頃な価格は、特に十分な医療サービスを受けていない患者層など、より広範な患者へのアクセスをさらに促進します。最近のバイオセンサーやマイクロ流体技術の動向は、感度と特異度を向上させた、より洗練されたPOC検査の開発を後押ししています。これらの技術革新により、単核球症の検出におけるPOC検査の信頼性が確保されています。POC検査キットを提供する単核球症診断市場のプレーヤーには、SEKISUI Diagnostics社（OSOM Mono Test）、Abbott社（Clearview Mono）、Cardinal Health社（Cardinal Health MONO（Mononucleosis）II Rapid Test）などがあります。このように、POC検査の開発は、単核球症診断市場のプレーヤーに実質的な成長機会を生み出しています。

単核球症診断市場レポートセグメンテーション分析

単核球症診断市場の分析に貢献した主要セグメントは、タイプとエンドユーザーです。

タイプ別では、単核球症診断市場はエプスタインバーウイルス抗体検査、全血球算定検査、モノスポット検査に区分されます。2023年の単核球症診断市場は、モノスポットテストセグメントが最大シェアを占めています。

エンドユーザー別では、単核球症診断市場は病院、研究所、その他に分類されます。2023年には病院セグメントが市場を独占しました。

単核球症診断市場競合情勢と主な発展

Abbott Laboratories、Arlington Scientific Inc、Bio-Rad Laboratories Inc、Cardinal Health Inc、Meridian Bioscience Inc、Sekisui Diagnostics LLC、Thermo Fisher Scientific Inc、QuidelOrtho Corp、F. Hoffmann-La Roche Ltd、QIAGEN NV、Hologic Inc、bioMerieux SA、DiaSorin SpA、Immunostics Inc、Launch Diagnostics Ltd、Biorex Diagnostics、ZEUS Scientificは、単核球症診断市場で事業を展開している主要企業です。

国連児童基金（UNICEF）、国立医学図書館、疾病管理予防センター（CDC）、国立衛生研究所、カナダ統計局、連邦統計局（Destatis）などは、単核球症診断市場レポート作成時に参照した一次情報および二次情報です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • 基礎数値の開発
    • データの三角測量
    • 国レベルのデータ

第4章 単核球症診断の市場情勢

  • PEST分析

第5章 単核球症診断市場-主要市場力学

  • 単核球症診断市場- 主要市場力学
  • 市場促進要因
    • 青少年層におけるハイリスク
    • 単核球症に関する健康意識と知識の高まり
  • 市場抑制要因
    • 既存の診断検査の精度の低さ
  • 市場機会
    • ポイントオブケア検査の開発
  • 今後の動向
    • 分子診断学の進歩
  • 促進要因と抑制要因の影響

第6章 単核球症診断市場：世界市場分析

  • 単核球症診断市場収益、2021-2031年
  • 単核球症診断の市場予測分析

第7章 単核球症診断市場分析- タイプ別

  • モノスポットテスト
  • エプスタインバーウイルス抗体検査
  • 全血球数検査

第8章 単核球症診断市場分析-エンドユーザー別

  • 病院
  • 研究所
  • その他

第9章 単核球症診断市場分析- 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • アジア太平洋地域のその他諸国
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他中南米
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • その他中東とアフリカ

第10章 業界情勢

  • 単核球症診断市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第11章 企業プロファイル

  • Abbott Laboratories
  • Arlington Scientific Inc
  • Bio-Rad Laboratories Inc
  • Cardinal Health Inc
  • Meridian Bioscience Inc
  • Sekisui Diagnostics LLC
  • Thermo Fisher Scientific Inc
  • QuidelOrtho Corp
  • F. Hoffmann-La Roche Ltd
  • QIAGEN NV
  • Hologic Inc
  • bioMerieux SA
  • DiaSorin SpA
  • Immunostics Inc.
  • Launch Diagnostics Ltd
  • Biorex Diagnostics
  • ZEUS Scientific

第12章 付録

図表

List Of Tables

  • Table 1. Mononucleosis Diagnostics Market Segmentation
  • Table 2. North America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 3. North America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 4. United States: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 5. United States: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 6. Canada: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 7. Canada: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 8. Mexico: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 9. Mexico: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 10. Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 11. Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 12. Germany: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 13. Germany: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 14. United Kingdom: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 15. United Kingdom: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 16. France: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 17. France: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 18. Italy: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 19. Italy: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 20. Spain: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 21. Spain: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 22. Rest of Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 23. Rest of Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 24. Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 25. Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 26. China: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 27. China: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 28. Japan: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 29. Japan: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 30. India: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 31. India: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 32. Australia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 33. Australia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 34. South Korea: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 35. South Korea: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 36. Rest of APAC: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 37. Rest of APAC: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 38. South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 39. South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 40. Brazil: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 41. Brazil: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 42. Argentina: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 43. Argentina: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 44. Rest of South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 45. Rest of South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 46. Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 47. Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 48. Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Country
  • Table 49. Saudi Arabia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 50. Saudi Arabia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 51. South Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 52. South Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 53. United Arab Emirates: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 54. United Arab Emirates: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 55. Rest of Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by Type
  • Table 56. Rest of Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand) - by End User
  • Table 57. Recent Organic Growth Strategies in Mononucleosis Diagnostic Market
  • Table 58. Recent Inorganic Growth Strategies in the Mononucleosis Diagnostic Market
  • Table 59. Glossary of Terms

List Of Figures

  • Figure 1. Mononucleosis Diagnostics Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Mononucleosis Diagnostics Market Revenue (US$ Thousand), 2021-2031
  • Figure 5. Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 6. Mononucleosis Diagnostics Market Share (%) - by Type (2023 and 2031)
  • Figure 7. Monospot Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 8. Epstein Barr Virus Antibody Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 9. Complete Blood Count Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 10. Mononucleosis Diagnostics Market Share (%) - by End User (2023 and 2031)
  • Figure 11. Hospital: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 12. Laboratories: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 13. Others: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • Figure 14. North America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 15. North America: Mononucleosis Diagnostics Market Breakdown, by Type (2023 and 2031)
  • Figure 16. North America: Mononucleosis Diagnostics Market Breakdown, by End User (2023 and 2031)
  • Figure 17. North America: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 18. United States: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 19. Canada: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 20. Mexico: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 21. Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 22. Europe: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 23. Germany: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 24. United Kingdom: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 25. France: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 26. Italy: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 27. Spain: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 28. Rest of Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 29. Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 30. Asia Pacific: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 31. China: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 32. Japan: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 33. India: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 34. Australia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 35. South Korea: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 36. Rest of APAC: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 37. South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 38. South and Central America: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 39. Brazil: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 40. Argentina: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 41. Rest of South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 42. Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 43. Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 44. Saudi Arabia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 45. South Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 46. United Arab Emirates: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 47. Rest of Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031(US$ Thousand)
  • Figure 48. Growth Strategies in Mononucleosis Diagnostic Market
目次
Product Code: TIPRE00019689

According to our new research study on "Mononucleosis Diagnostic Market Forecast to 2031 -Global Analysis - by Type, End User, and Geography," the market is anticipated to grow from US$ 151.44 million in 2023 and is projected to reach US$ 222.15 million by 2031; it is expected to register a CAGR of 4.9% during 2023-2031. High risk among the adolescent population, and the rising health awareness and knowledge about mononucleosis are contributing to the growing mononucleosis diagnostic market size. However, the low accuracy of existing diagnostic tests hampers the mononucleosis diagnostic market growth. Further, advancements in molecular diagnostics in mononucleosis diagnostic are expected to bring in new mononucleosis diagnostic market trends in the coming years.

In terms of revenue, North America dominated the mononucleosis diagnostic market in 2023. It is estimated to dominate the global market during the forecast period. The US is the largest market for mononucleosis diagnostics in the world, and it is estimated to dominate the market during the forecast period as well. The mononucleosis diagnostic market growth in the US is attributed to technological advancements, increased awareness, and a constant need for effective disease management strategies. According to the National Institutes of Health, the US records ~125,000 cases of infectious mononucleosis every year. Owing to such a high number, the awareness of the mononucleosis caused by the Epstein-Barr virus (EBV) is also on the rise in the country, which bolsters the demand for rapid and accurate diagnostic test kits, consumables, and services. Various testing methods adopted by healthcare providers in the country include serological tests based on antibody detection and molecular tests focused on viral DNA identification. The competitive landscape of the mononucleosis diagnostics market in the US is dominated by companies such as Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers. These companies invest in innovation and collaborations to enhance their product offerings and expand their market presence.

Mononucleosis Diagnostic Market Analysis

Development of Point-of-Care Testing to Provide Market Opportunities in Future

POC testing allows for rapid diagnosis at or near the site of patient care, enabling healthcare providers to make immediate clinical decisions and improve patient outcomes. Traditional laboratory tests often require hours or days to generate results, which can delay treatment and worsen symptoms. In contrast, POC tests can deliver results within minutes, facilitating timely intervention. The rapid turnaround is especially crucial for conditions such as mononucleosis, as early diagnosis can reduce complications and enhance patient comfort. POC testing can be implemented in various healthcare settings, including outpatient clinics, emergency departments, and home care settings. The accessibility is particularly beneficial in areas with limited laboratory infrastructure or in rural regions with insufficient healthcare resources. Bringing diagnostic capabilities closer to patients in the form of POC testing ensures that more individuals receive timely diagnoses and appropriate care, thereby broadening the reach of healthcare services. Moreover, this type of testing promotes greater engagement, as patients can receive their results quickly and discuss the next steps with their healthcare providers.

POC testing can be more cost-effective compared to traditional laboratory testing as they don't need extensive laboratory infrastructure, in turn lowering the overall costs for healthcare systems. The affordability of mononucleosis testing further drives its accessibility to a broader range of patients, especially in underserved populations. Recent advancements in biosensors and microfluidic technologies are driving the development of more sophisticated POC tests with improved sensitivity and specificity. These innovations ensure the reliability of POC tests in detecting mononucleosis. Mononucleosis diagnostic market players offering POC test kits include SEKISUI Diagnostics (OSOM Mono Test), Abbott (Clearview Mono), and Cardinal Health [Cardinal Health MONO (Mononucleosis) II Rapid Test]. Thus, the development of POC testing generates substantial growth opportunities for the mononucleosis diagnostics market players.

Mononucleosis Diagnostic Market Report Segmentation Analysis

Key segments that contributed to the derivation of the mononucleosis diagnostic market analysis are type and end user.

Based on type, the mononucleosis diagnostic market is segmented into Epstein Barr Virus antibody test, complete blood count test, and monospot test. The monospot test segment held the largest mononucleosis diagnostic market share of the market in 2023.

In terms of end user, the mononucleosis diagnostic market is categorized into hospitals, laboratories, and others. The hospitals segment dominated the market in 2023.

Mononucleosis Diagnostic Market: Competitive Landscape and Key Developments

Abbott Laboratories, Arlington Scientific Inc, Bio-Rad Laboratories Inc, Cardinal Health Inc, Meridian Bioscience Inc, Sekisui Diagnostics LLC, Thermo Fisher Scientific Inc, QuidelOrtho Corp, F. Hoffmann-La Roche Ltd, QIAGEN NV, Hologic Inc, bioMerieux SA, DiaSorin SpA, Immunostics Inc., Launch Diagnostics Ltd, Biorex Diagnostics, and ZEUS Scientific are among the key companies operating in the mononucleosis diagnostic market.

The United Nations Children's Fund (UNICEF), National Library of Medicine, Centers for Disease Control and Prevention (CDC), National Institutes of Health, Statistics Canada, Federal Statistical Office (Destatis) are among the primary and secondary sources referred to while preparing the mononucleosis diagnostic market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Mononucleosis Diagnostics Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Mononucleosis Diagnostics Market - Key Market Dynamics

  • 5.1 Mononucleosis Diagnostics Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 High Risk among Adolescent Population
    • 5.2.2 Rising Health Awareness and Knowledge About Mononucleosis
  • 5.3 Market Restraints
    • 5.3.1 Low Accuracy of Existing Diagnostic Tests
  • 5.4 Market Opportunities
    • 5.4.1 Development of Point-of-Care Testing
  • 5.5 Future Trends
    • 5.5.1 Advancements in Molecular Diagnostics
  • 5.6 Impact of Drivers and Restraints:

6. Mononucleosis Diagnostics Market - Global Market Analysis

  • 6.1 Mononucleosis Diagnostics Market Revenue (US$ Thousand), 2021-2031
  • 6.2 Mononucleosis Diagnostics Market Forecast Analysis

7. Mononucleosis Diagnostics Market Analysis - by Type

  • 7.1 Monospot Test
    • 7.1.1 Overview
    • 7.1.2 Monospot Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 7.2 Epstein Barr Virus Antibody Test
    • 7.2.1 Overview
    • 7.2.2 Epstein Barr Virus Antibody Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 7.3 Complete Blood Count Test
    • 7.3.1 Overview
    • 7.3.2 Complete Blood Count Test: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)

8. Mononucleosis Diagnostics Market Analysis - by End User

  • 8.1 Hospital
    • 8.1.1 Overview
    • 8.1.2 Hospital: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.2 Laboratories
    • 8.2.1 Overview
    • 8.2.2 Laboratories: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
  • 8.3 Others
    • 8.3.1 Overview
    • 8.3.2 Others: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)

9. Mononucleosis Diagnostics Market - Geographical Analysis

  • 9.1 North America
    • 9.1.1 North America Mononucleosis Diagnostics Market Overview
    • 9.1.2 North America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
    • 9.1.3 North America: Mononucleosis Diagnostics Market Breakdown, by Type
      • 9.1.3.1 North America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
    • 9.1.4 North America: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.1.4.1 North America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.1.5 North America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.1.5.1 United States: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.1.5.1.1 United States: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.1.5.1.2 United States: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.1.5.2 Canada: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.1.5.2.1 Canada: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.1.5.2.2 Canada: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.1.5.3 Mexico: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.1.5.3.1 Mexico: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.1.5.3.2 Mexico: Mononucleosis Diagnostics Market Breakdown, by End User
  • 9.2 Europe
    • 9.2.1 Europe Mononucleosis Diagnostics Market Overview
    • 9.2.2 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.2.2.1 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
      • 9.2.2.2 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.2.3 Europe: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.2.3.1 Germany: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.1.1 Germany: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.2.3.1.2 Germany: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.2.3.2 United Kingdom: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.2.1 United Kingdom: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.2.3.2.2 United Kingdom: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.2.3.3 France: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.3.1 France: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.2.3.3.2 France: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.2.3.4 Italy: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.4.1 Italy: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.2.3.4.2 Italy: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.2.3.5 Spain: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.5.1 Spain: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.2.3.5.2 Spain: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.2.3.6 Rest of Europe: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.2.3.6.1 Rest of Europe: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.2.3.6.2 Rest of Europe: Mononucleosis Diagnostics Market Breakdown, by End User
  • 9.3 Asia Pacific
    • 9.3.1 Asia Pacific Mononucleosis Diagnostics Market Overview
    • 9.3.2 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.3.2.1 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
      • 9.3.2.2 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.3.3 Asia Pacific: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.3.3.1 China: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.1.1 China: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.3.3.1.2 China: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.3.3.2 Japan: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.2.1 Japan: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.3.3.2.2 Japan: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.3.3.3 India: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.3.1 India: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.3.3.3.2 India: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.3.3.4 Australia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.4.1 Australia: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.3.3.4.2 Australia: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.3.3.5 South Korea: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.5.1 South Korea: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.3.3.5.2 South Korea: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.3.3.6 Rest of APAC: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.3.3.6.1 Rest of APAC: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.3.3.6.2 Rest of APAC: Mononucleosis Diagnostics Market Breakdown, by End User
  • 9.4 South and Central America
    • 9.4.1 South and Central America Mononucleosis Diagnostics Market Overview
    • 9.4.2 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.4.2.1 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
      • 9.4.2.2 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.4.3 South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.4.3.1 Brazil: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.4.3.1.1 Brazil: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.4.3.1.2 Brazil: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.4.3.2 Argentina: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.4.3.2.1 Argentina: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.4.3.2.2 Argentina: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.4.3.3 Rest of South and Central America: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.4.3.3.1 Rest of South and Central America: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.4.3.3.2 Rest of South and Central America: Mononucleosis Diagnostics Market Breakdown, by End User
  • 9.5 Middle East and Africa
    • 9.5.1 Middle East and Africa Mononucleosis Diagnostics Market Overview
    • 9.5.2 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
      • 9.5.2.1 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Type
      • 9.5.2.2 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.5.3 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.5.3.1 Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.5.3.2 Saudi Arabia: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.5.3.2.1 Saudi Arabia: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.5.3.2.2 Saudi Arabia: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.5.3.3 South Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.5.3.3.1 South Africa: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.5.3.3.2 South Africa: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.5.3.4 United Arab Emirates: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.5.3.4.1 United Arab Emirates: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.5.3.4.2 United Arab Emirates: Mononucleosis Diagnostics Market Breakdown, by End User
      • 9.5.3.5 Rest of Middle East and Africa: Mononucleosis Diagnostics Market - Revenue and Forecast to 2031 (US$ Thousand)
        • 9.5.3.5.1 Rest of Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by Type
        • 9.5.3.5.2 Rest of Middle East and Africa: Mononucleosis Diagnostics Market Breakdown, by End User

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Mononucleosis Diagnostic Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Arlington Scientific Inc
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Bio-Rad Laboratories Inc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Cardinal Health Inc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Meridian Bioscience Inc
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Sekisui Diagnostics LLC
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Thermo Fisher Scientific Inc
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 QuidelOrtho Corp
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 F. Hoffmann-La Roche Ltd
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 QIAGEN NV
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 Hologic Inc
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Products and Services
    • 11.11.4 Financial Overview
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments
  • 11.12 bioMerieux SA
    • 11.12.1 Key Facts
    • 11.12.2 Business Description
    • 11.12.3 Products and Services
    • 11.12.4 Financial Overview
    • 11.12.5 SWOT Analysis
    • 11.12.6 Key Developments
  • 11.13 DiaSorin SpA
    • 11.13.1 Key Facts
    • 11.13.2 Business Description
    • 11.13.3 Products and Services
    • 11.13.4 Financial Overview
    • 11.13.5 SWOT Analysis
    • 11.13.6 Key Developments
  • 11.14 Immunostics Inc.
    • 11.14.1 Key Facts
    • 11.14.2 Business Description
    • 11.14.3 Products and Services
    • 11.14.4 Financial Overview
    • 11.14.5 SWOT Analysis
    • 11.14.6 Key Developments
  • 11.15 Launch Diagnostics Ltd
    • 11.15.1 Key Facts
    • 11.15.2 Business Description
    • 11.15.3 Products and Services
    • 11.15.4 Financial Overview
    • 11.15.5 SWOT Analysis
    • 11.15.6 Key Developments
  • 11.16 Biorex Diagnostics
    • 11.16.1 Key Facts
    • 11.16.2 Business Description
    • 11.16.3 Products and Services
    • 11.16.4 Financial Overview
    • 11.16.5 SWOT Analysis
    • 11.16.6 Key Developments
  • 11.17 ZEUS Scientific
    • 11.17.1 Key Facts
    • 11.17.2 Business Description
    • 11.17.3 Products and Services
    • 11.17.4 Financial Overview
    • 11.17.5 SWOT Analysis
    • 11.17.6 Key Developments

12. Appendix

  • 12.1 About the Insight Partners
  • 12.2 Glossary of Terms for Mononucleosis Diagnostics Market